Variations of transition zone volume and transition zone index after transurethral needle ablation for symptomatic benign prostatic hyperplasia

International Journal of Urology

Volumn 10, Issue 7, 2003, Pages 392-397

  Fujimoto, Kiyohide ^a   Hosokawa, Yukinari ^a   Tomioka, Atsushi ^a   Yamamoto, Hiroaki ^a   Tanaka, Yozo ^a   Otani, Takeshi ^a   Ozono, Seiichiro ^a   Hirao, Yoshihiko ^a   Hayashi, Yoshiki ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b University of Occupational and Environmental Health   (Japan)

Author keywords

Benign prostatic hyperplasia; Transition zone index; Transition zone volume; Transurethral needle ablation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; HUMAN; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; TRANSURETHRAL NEEDLE ABLATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; REOPERATION; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 0041703069     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00648.x     Document Type: Article

References (15)

1. Koshiba K, Miki M, Terachi T, Uchida T (eds). Treatment of Benign Prostatic Hyperplasia (Recent Advances in Endourology 2). Springer,Tokyo, 2000.
2. Roehrborn CG, Issa MM, Bruskewitz RC et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. S Study. Urology 1998; 51: 415-21.
3. Bruskewitz R, Issa MM, Roehrborn CG et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J. Urol. 1998; 159: 1588-94.
4. Kahn SA, Alphonse P, Tewari A, Narayan P. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: The University of florida experience. J. Urol. 1998; 160: 1695-700.
5. Braun M, Zumbé J, Korte D, Solleder G, Heidenreich A, Engelmann U. Transurethral needle ablation of the prostate: An alternative minimally invasive therapeutic concept in the treatment of benign prostate hyperplasia. Urol. Int. 1998; 61: 104-10.
6. Namiki K, Shiozawa H, Tsuzuki M, Mamiya Y, Matsumoto T, Miki M. Efficacy of transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia. Int. J. Urol. 1999; 6: 341-5.
7. Roehrborn CG, Burkhard FC, Bruskewitz CR et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: Analysis of the United States randomized study. J. Urol. 1999; 162: 92-7.
8. Murai M, Tachibana M, Miki M, Shiozawa H, Hirao Y, Okajima E. Transurethral needle ablation of the prostate: An initial Japanese clinical trial. Int. J. Urol. 2001; 8: 99-105.
9. Homma Y, Kawabe K, Tsukamoto T et al. Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int. J. Urol. 1996; 3: 261-6.
10. Homma Y, Kawabe K, Tsukamoto T et al. Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int. J. Urol. 1996; 3: 267-73.
11. Ozono S, Otani T, Tani Y, Hirao Y. Long-term results of TUNA for benign prostatic hyperplasia (in Japanese). Jpn. J. Endourol. ESWL 2001; 14: 127-32.
12. Zlotta AR, Raviv G, Peny MO, Noel JC, Schulman CC. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J. Urol. 1997; 157: 894-9.
13. Otani T, Hayashi Y, Kishino T et al. A new parameter in decision making for transurethral electroresection of benign prostate hyperplasia. Eur. Urol. 1999; 35: 185-91.
14. Millard RJ, Harewood LM, Tamaddon K. A study of efficacy and safety of transurethral needle ablation (TUNA) treatment for benign prostatic hyperplasia. Neurourol. Urodyn. 1996; 15: 619-29.
15. Zlotta AR, Peny MO, Matos C, Schulman CC. Transurethral needle ablation of the prostate: Clinical experience in patients in urinary acute retention. Br. J. Urol. 1996; 77: 391-7.